REGULATED PRESS RELEASE published on 01/26/2026 at 17:45, 9 months 22 days ago Gimv verhoogt focus op strategische doelstellingen en discontinueert activiteiten voor nieuwe Life Sciences investeringen Gimv verhoogt focus op strategische doelstellingen en stopt met Life Sciences investeringen. Raad van bestuur richt zich op Anchor, Consumer, Healthcare, Smart Industries en Sustainable Cities voor groei Gimv Life Sciences Groei Investeringen Strategische Doelstellingen
REGULATED PRESS RELEASE published on 01/26/2026 at 17:45, 9 months 22 days ago Gimv increases focus on strategic objectives and discontinues activities for new Life Sciences investments Gimv verlagert den Fokus auf strategische Ziele und stellt Aktivitäten für neue Life-Sciences-Investitionen ein Gimv Life Sciences Wachstum Investitionen Strategische Ziele
BRIEF published on 01/20/2026 at 07:35, 9 months 28 days ago Gimv Leads €51 Million Investment in Exciva for Alzheimer's Therapy Series B Funding Gimv Investment Exciva GmbH Alzheimer’s Therapy Deraphan Trial
BRIEF published on 01/20/2026 at 07:35, 9 months 28 days ago Investissement de 51 millions d'euros dans Exciva pour traiter Alzheimer Investissement Gimv Alzheimer Biopharmaceutique Essai Clinique
REGULATED PRESS RELEASE published on 01/20/2026 at 07:30, 9 months 28 days ago Gimv leads € 51 million Series B investment round in Exciva to advance innovative Alzheimer’s therapy Exciva secures €51m funding led by Gimv and EQT for Alzheimer's therapy. Deraphan targets agitation in Phase II trial, promising improved care for patients Funding Phase II Trial Exciva Alzheimer's Therapy Deraphan
REGULATED PRESS RELEASE published on 01/20/2026 at 07:30, 9 months 28 days ago Gimv leidt een Series B investeringsronde van EUR 51 miljoen in Exciva voor verdere ontwikkeling van een innovatieve Alzheimerbehandeling Gimv leidt een Series B investeringsronde van EUR 51 miljoen in Exciva voor verdere ontwikkeling van een innovatieve Alzheimerbehandeling Gimv Series B EUR 51 Miljoen Exciva Alzheimerbehandeling
REGULATED PRESS RELEASE published on 01/20/2026 at 07:30, 9 months 28 days ago Gimv leads € 51 million Series B investment round in Exciva to advance innovative Alzheimer’s therapy Gimv mène une levée de fonds de 51 millions d'euros pour Exciva afin de faire avancer une thérapie innovante contre la maladie d'Alzheimer Investissement Gimv Alzheimer Thérapie Exciva
BRIEF published on 01/16/2026 at 07:35, 10 months 1 day ago Gimv Sells Majority Stake in ALT Technologies to CCL Industries Acquisition Automotive Industry Gimv CCL Industries ALT Technologies
BRIEF published on 01/16/2026 at 07:35, 10 months 1 day ago Gimv cède sa participation majoritaire dans ALT Technologies à CCL Industries Cession Investissement Industrie Automobile Expansion Mondiale Composants Adhésifs
REGULATED PRESS RELEASE published on 01/16/2026 at 07:30, 10 months 1 day ago Gimv verkoopt meerderheidsbelang in ALT Technologies aan CCL Industries Gimv verkoopt meerderheidsbelang in ALT Technologies aan CCL Industries, versterkt positie in automobielsector en duurzame toepassingen Gimv CCL Industries ALT Technologies Verkoop Meerderheidsbelang Automobielsector
Published on 11/18/2026 at 00:35, 2 hours 12 minutes ago Route1 Appoints Tom Park to Board of Directors and Announces Board Changes
Published on 11/17/2026 at 23:40, 3 hours 7 minutes ago AI/ML Innovations Inc. Closes First Tranche of Private Placement
Published on 11/17/2026 at 23:00, 3 hours 47 minutes ago Alset AI Ventures Inc. Announces Extension of Annual General Meeting Deadline
Published on 11/17/2026 at 21:30, 5 hours 17 minutes ago Fairplay Ventures INC. Announces Filing of Filing Statement in Connection With Qualifying Transaction
Published on 11/17/2026 at 15:00, 11 hours 47 minutes ago Secure Blockchain's Agentic Solutions Signs Engineering Company, Expanding Enterprise AI Into Heavy Industry
Published on 11/18/2026 at 01:55, 52 minutes ago WIRobotics and Ottobock Join Forces to Expand Access to Wearable Robots Across North America
Published on 11/18/2026 at 01:40, 1 hour 7 minutes ago AMPERA and Berto Announce Proposed Business Combination to Accelerate Advanced Energy Technology Development and Commercialization
Published on 11/18/2026 at 00:59, 1 hour 48 minutes ago Linedata Services: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 11/17/2026 at 23:13, 3 hours 34 minutes ago EQS-Adhoc: M1 Kliniken AG plans move to the Prime Standard in 2027 and raises EBIT margin target for its Beauty segment to at least 25%
Published on 11/17/2026 at 22:00, 4 hours 47 minutes ago Linedata Services: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 11/17/2026 at 18:00, 8 hours 47 minutes ago 20261117 - Accor - Accor to increase its stake in Ennismore
Published on 11/17/2026 at 18:00, 8 hours 47 minutes ago Accor - Accor se renforce au capital de Ennismore
Published on 11/17/2026 at 17:45, 9 hours 2 minutes ago EURAZEO COMPLETES THE SALE OF ITS STAKE IN AROMA-ZONE AND ITS REINVESTMENT ALONGSIDE PARTNERS GROUP
Published on 11/17/2026 at 17:45, 9 hours 2 minutes ago EURAZEO FINALISE LA CESSION DE SA PARTICIPATION DANS AROMA-ZONE ET SON REINVESTISSEMENT AUX COTES DE PARTNERS GROUP
Published on 11/17/2026 at 07:40, 19 hours 6 minutes ago SUEZ INTERNATIONAL SAS COMPLETES THE SALE OF C.10.65 MILLION SHARES OF ACEA S.P.A.